Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Pfizer
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00952380
First received: August 4, 2009
Last updated: November 1, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)